ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 229 filers reported holding ARRAY BIOPHARMA INC in Q2 2018. The put-call ratio across all filers is 1.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $516,000 | -37.3% | 21,200 | -56.8% | 0.03% | +76.5% |
| Q2 2018 | $823,000 | -77.8% | 49,100 | -88.9% | 0.02% | -69.6% |
| Q2 2017 | $3,713,000 | +7800.0% | 443,700 | +2673.1% | 0.06% | +2700.0% |
| Q1 2016 | $47,000 | -81.3% | 16,000 | -71.1% | 0.00% | -89.5% |
| Q3 2015 | $252,000 | -48.5% | 55,400 | -16.6% | 0.02% | -59.6% |
| Q1 2015 | $489,000 | – | 66,400 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Advisory Services Network, LLC | 3,442 | $159,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |